Cigna Group
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
CI$295.60+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FS-4
STATEMENTS OF CASH FLOWS
| For the Years Ended December 31, | |||
|---|---|---|---|
| (In millions) | 2025 | 2024 | 2023 |
| Cash Flows from Operating Activities | |||
| Shareholders' net income | $5,957 | $3,434 | $5,164 |
| Adjustments to reconcile Shareholders' net income to net cash provided by operating activities | |||
| Equity in income from subsidiaries | (1,746) | (4,154) | (5,886) |
| Dividends received from subsidiaries | 1,171 | 2,916 | 1,381 |
| Gain on sale of businesses | (4,890) | — | — |
| Other liabilities | 496 | (306) | 540 |
| Other, net | 592 | 243 | 640 |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 1,580 | 2,133 | 1,839 |
| Cash Flows from Investing Activities | |||
| Net change in amounts due from affiliates | — | — | 622 |
| Proceeds from divestiture of businesses | 4,891 | — | — |
| NET CASH PROVIDED BY INVESTING ACTIVITIES | 4,891 | — | 622 |
| Cash Flows from Financing Activities | |||
| Net change in amounts due to/from affiliates | (1,101) | 4,761 | 1,473 |
| Net change in commercial paper | (880) | (357) | 1,237 |
| Repayment of term loan | (2,000) | — | — |
| Net proceeds on issuance of term loan | 1,999 | — | — |
| Repayment of long-term debt | (3,861) | (2,731) | (2,822) |
| Net proceeds on issuance of long-term debt | 4,458 | 4,462 | 1,491 |
| Issuance of common stock | 203 | 305 | 187 |
| Common stock dividend paid | (1,611) | (1,567) | (1,450) |
| Repurchase of common stock | (3,621) | (7,034) | (2,284) |
| Other, net | (108) | (117) | (110) |
| NET CASH USED IN FINANCING ACTIVITIES | (6,522) | (2,278) | (2,278) |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (51) | (145) | 183 |
| Cash, cash equivalents and restricted cash, beginning of year | 190 | 335 | 152 |
| Cash, cash equivalents and restricted cash, end of year (1) | $139 | $190 | $335 |
| Noncash Investing and Financing Activities: | |||
| Net amounts due from affiliates settled through capital transactions | $(1,617) | $(7,565) | $(5,221) |
(1) Includes restricted cash reported in Other non-current assets.
FS-4
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.